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Adenosine deaminases acting on RNA (ADARs)
convert adenosine to inosine, which is then recog-
nized as guanosine. To study the role of ADAR pro-
teins in RNA editing and gene regulation, we
sequenced and compared the DNA and RNA of
human B cells. Then, we followed up the findings
experimentally with siRNA knockdown and RNA
and protein immunoprecipitations. The results un-
covered over 60,000 A-to-G editing sites and several
thousand genes whose expression levels are influ-
enced by ADARs. Of these ADAR targets, 90%
were identified. Our results also reveal that ADAR
regulates transcript stability and gene expression
through interaction with HuR (ELAVL1). These
findings extend the role of ADAR and show that it
cooperates with other RNA-processing proteins to
regulate the sequence and expression of transcripts
in human cells.INTRODUCTION
Molecular studies and, more recently, genome and transcrip-
tome sequencing have uncovered the complexity of RNA pro-
cessing. From the same DNA templates, events such as RNA
editing generate different forms of transcripts. In this study, we
focused on ADAR-mediated RNA editing and its interactions
with other RNA processing steps to regulate gene expression.
In human cells, two classes of proteins are known to be involved
in RNA editing: the ADAR and APOBEC families. ADARs, which
are expressed in a wide variety of cell types, deaminate adeno-
sine to inosine, which is then recognized by the translation and
splicing machineries as guanosine (Bass and Weintraub, 1988;
Kim et al., 1994; Rueter et al., 1995; Yang et al., 1995). APOBEC1
is expressed predominantly in human liver and converts cytidine
to uridine (C-to-U) (Chen et al., 1987; Powell et al., 1987). There
are only a few characterized targets of human APOBEC1, the
APOB and NF1 genes.CeRecent work has uncovered many more RNA-editing events
mediated by ADAR proteins. These findings led to new ques-
tions. Most of the A-to-G editing sites were identified by com-
putational analysis of sequence data without experimental
validation. Some of the findings were based on a comparison
of RNA sequences with reference DNA sequences that were
not derived from the same cells. In addition, it has been sug-
gested that ADAR plays a role in other biological processes
in an editing-independent manner (Clerzius et al., 2009; Heale
et al., 2009), but the extent of these processes is not known.
Lastly, it is not clear whether ADAR1 and ADAR2 play the
same role or different roles in human cells. To address these
issues, we sought to answer three main questions: (1) What
sites do ADAR proteins edit? (2) Do ADAR proteins regulate
gene expression, and if so, is this regulation dependent on
editing? (3) What other proteins interact with ADARs in RNA
processing?
We compared DNA and RNA sequences in human B cells from
two individuals to identify RNA-DNA sequence differences
(RDDs). We validated the findings by RNAi and RNA immunopre-
cipitation (RNA-IP). The results uncovered 10,000 known and
50,000 unknown ADAR-mediated A-to-G editing sites in
premature and mature mRNAs and long noncoding RNAs
(lncRNAs). We also found that ADAR proteins have an editing-
independent effect on gene expression. Our results showed
that ADAR1 interacts with HuR (ELAVL1) to regulate transcript
stability. Together, these results provided us with a deeper
understanding of ADAR proteins in RNA editing and gene
regulation.RESULTS
DNA and RNA Sequencing
We sequenced the DNA and mRNA from cultured B cells of two
individuals using Illumina-based next-generation sequencing
(NGS) (Bentley et al., 2008). We conducted DNA sequencing
(DNA-seq) to >303 coverage and obtained >140 million RNA
sequencing (RNA-seq) reads for each sample. At least 80% of
the sequence reads mapped to the reference genome sequence
(Table S1). For each individual, we compared their DNA and
mRNA sequences to identify editing and other types of RDDsll Reports 5, 849–860, November 14, 2013 ª2013 The Authors 849
Figure 1. Identification of RDDs
(A) Analysis steps to identify RDDs (see also the Supplemental Experimental Procedures). All 12 types of RDDs were found.
(B) Sites detected genome wide.
(C) Sites detected in non-Alu regions.
See also Tables S1 and S2.(Chen et al., 2012; Ju et al., 2011; Li et al., 2011). Data from
strand-specific (directional) sequencing allowed us to annotate
all 12 types of possible mismatches between DNA and RNA
sequences. To simplify the mapping of the sequence reads,
repetitive sequences are often excluded. However, since most
of the ADAR-mediated A-to-G editing sites were found in Alu
repeats (Athanasiadis et al., 2004; Kim et al., 2004; Levanon
et al., 2004; Peng et al., 2012), we retained Alu sequences
(but excluded other sequence repeats) in our analysis. Using
stringent thresholds, we identified 10,992 sites where the RNA
sequences were discordant from the corresponding DNA se-
quences in both individuals (Figure 1A; Table S2). All 12 types
of RDDs (A-to-C, A-to-G, etc.) were found (Figure 1B). These
included 9,675 sites in Alu-containing regions and 1,317 sites
in nonrepetitive regions of the genome. The distributions of the
12 types of RDDs were very different for Alu-containing and
Alu-free regions of the genome. Most (99%) of the sites in Alu
regions were A-to-G editing sites, whereas in regions without
Alu repeats, only 57% were A-to-G sites (Figure 1C). We then
validated the results by Sanger sequencing and emulsion-based
droplet digital PCR (Figures 2 and S1). Twenty-four out of 25850 Cell Reports 5, 849–860, November 14, 2013 ª2013 The Authorssites were validated by Sanger sequencing, and five out of six
sites were validated by droplet digital PCR. Thus, the false
discovery rate (FDR) is approximately 6.5% (Figure S1).
ADAR1 Plays a Major Role in A-to-G RNA Editing
in Human B Cells
To assess the extent to which the ADAR family of deaminases
contributes to mismatches between RNA and corresponding
DNA sequences, we carried out RNAi-mediated gene knock-
downs and deep sequencing of the resulting cells. HumanB cells
possess three members of the ADAR family: ADAR1, ADAR2,
and ADAR3. ADAR1 and ADAR2 are functional deaminases
(Bass and Weintraub, 1988; Kim et al., 1994), whereas ADAR3
does not have a known enzymatic function (Chen et al., 2000).
The expression level of ADAR1 is >20 times higher than that of
ADAR2 and ADAR3 (reads per kilobase of transcript per million
mapped reads [RPKM] of ADAR1 = 7 compared with RPKM of
ADAR2 and ADAR3 < 0.3), suggesting that ADAR1 is the pre-
dominant form of ADARs in human B cells. Following gene
knockdown with four independent siRNAs and a pool
comprising the four siRNAs, ADAR1 was reduced by >50% at
Figure 2. Validation of A-to-G Editing and RDD Sites by Sanger Sequencing
(A) Sequences surrounding editing or RDD sites were amplified by PCR using genomic DNA or cDNA from the same two individuals as templates. The sites
validated by Sanger sequencing are highlighted in blue and the corresponding nucleotide changes are labeled. Some samples were sequenced from the reverse
strand, and the nucleotides are labeled according to the forward strand. *An example of an editing site in ERO1L that did not meet our inclusion criteria but
nonetheless was validated by Sanger sequencing.
(B) Hyperedited region in ATM transcript. 30 UTR of ATM was PCR amplified from cDNA and cloned. Sequences from 137 individual clones are illustrated. Each
black dot represents an A-to-G site detected in a clone by Sanger sequencing.
See also Figure S1.mRNAand protein levels (Figures 3A, 3B, S2A, and S2B). The ed-
iting activities were also reduced, as A-to-G editing in EIF2AK2
mRNA, a known target of ADAR1 (Blow et al., 2004), was abol-
ished following ADAR1 knockdown (Figures 3C and S2C).
Similar results were obtained from the different siRNAs; for sub-
sequent experiments, we used the pooled siRNAs to minimizeCeoff-target effects (Supplemental Experimental Procedures; Fig-
ure S2; Grimson et al., 2007).
Next, we sequenced and compared the DNA and RNA of
the siRNA-treated B cells. This allowed us to experimentally
validate the editing sites and determine the effect of ADAR1
on editing. False-positive results due to misalignment ofll Reports 5, 849–860, November 14, 2013 ª2013 The Authors 851
Figure 3. siRNA Knockdown of ADAR1 Resulted in Reduced A-to-G Levels
(A) Left panel: real-time RT-PCR shows the decrease in the ADAR1 mRNA level following knockdown using pooled siRNA. The average fold change from
triplicates is shown. Error bar indicates SEM. Right panel: western blot shows the decrease of ADAR1 protein following knockdown.
(B) Immunofluorescence staining of primary fibroblast confirmed that siRNA knockdown results in a decrease of ADAR1 expression. Left panel: representative
immunofluorescence image of primary fibroblasts treated with nontargeting control siRNA (NTC) or ADAR1-siRNA. Right panel: fluorescence quantification of
ADAR1 expression in 24 cells treated with NTC-siRNA or ADAR1-siRNA, respectively.
(C) Editing levels at two A-to-G sites in EIF2AK2 were reduced following ADAR1 knockdown, but the levels increased following ADAR2 knockdown and were
abolished following double knockdown.
(D) ADAR1 knockdown led to reduced levels in 96% A-to-G sites, but had a minimal effect on other types of RDDs.
See also Figures S2–S4 and Tables S3, S6, and S7.sequence reads or other artifacts would not ‘‘respond’’ to
siRNA treatments.
ADAR and RNAi pathways work cooperatively (Scadden and
Smith, 2001; Wu et al., 2011; Yang et al., 2005), so the double-
stranded RNAs (dsRNAs) used in gene knockdown likely have
effects on ADAR function other than knockdown of its expres-
sion level. To study the specific effects of ADAR1 knockdown,
we compared the sequences of cells transfected with control
siRNAs with those of cells treated with pooled ADAR1-specific
siRNAs. In the cells treated with control siRNA, we found 6,996
sites where the RNA and DNA sequences were discordant,
including 6,524 A-to-G editing sites. In the ADAR1 knockdown
cells, the editing level of 6,258 (96%) sites decreased by 20%
or more in samples from both individuals, whereas only 43 sites
of the other 11 types of RDDs decreased by the same extent
(Figure 3D; Table S3). A small number of sites (91 of the A-to-G
sites and 125 of the other RDDs) showed increased levels
following ADAR1 knockdown. The editing levels of >2,000852 Cell Reports 5, 849–860, November 14, 2013 ª2013 The AuthorsA-to-G sites were reduced to zero following ADAR1 knockdown.
These included sites in genes that encode caspases (CASP8 and
CASP10) and the von Hippel-Lindau (VHL) tumor suppressor,
which have been implicated in various cancers. In contrast, the
levels of the other types of RDDs did not change or decreased
very modestly. This suggests that ADAR1 mediates the majority
of A-to-G editing in B cells and does not contribute to the other
types of RDDs. In addition, these results show that the FDR of
A-to-G editing is no more than 4%.
The above data were obtained at one time point. In order to
study the kinetics of A-to-G editing, we carried out RNA-seq
on the cells at several time points after siRNA transfection. The
expression level of ADAR1 and the editing levels of its many
targets remained low throughout the time course (Figures S3A
and S3B). For instance, the A-to-G editing levels in TRAF1,
CENPH, and USP46 were less than 5% of those in control
samples 96 hr after siRNA transfection. Gene Ontology analysis
(Ashburner et al., 2000; Huang et al., 2009a, 2009b) showed that
Figure 4. Role of ADAR2 in RNA Editing
(A) Real-time RT-PCR shows that the ADAR2 mRNA level is downregulated following siRNA knockdown. We were unable to assess changes in the ADAR2
protein level because none of the antibodies we tested gave a specific ADAR2 signal in western blot. Error bar indicates SEM.
(B) ADAR2 knockdown led to changes of editing levels in 2,000 A-to-G sites. See also Table S4.
(C) Western blot shows that the ADAR1 protein level is not upregulated following ADAR2 knockdown.
(D) ADAR1 targets more editing sites than ADAR2. The Venn diagram shows shared and unique editing sites targeted by ADAR1 and ADAR2.
(E) Anti-ADAR1 RNA-IP pulled down ADAR1 protein and its associated editing targets specifically. Western blot shows that anti-ADAR1 pulled down
ADAR1 protein.
(F) RT-PCR shows that ADAR1 antibody pulled down transcripts of the editing targets, EIF2AK2 and AZIN1, but not the negative control transcript, PPWD1.
See also Figure S2 and Table S5.editing targets are enriched for genes that encode zinc-finger
proteins (p < 0.05), as well as proteins that are involved in chro-
mosomal organization (p < 105) and antiviral defense (p < 103).
Role of ADAR2 in RNA Editing in Human B Cells
Next, we carried out siRNA knockdown of ADAR2 (ADARB1)
followed by nucleic acid sequencing. The ADAR2 mRNA level
was reduced by 25% (Figures 4A and S2A). The lack of specific
antibodies prevented us frommeasuring ADAR2 protein expres-
sion. Following ADAR2 knockdown, we observed a decrease
in its activity: the editing levels of 2,181 of 6,084 A-to-G sitesCe(Table S4), and 32 of the other types of RDDs decreased by at
least 20%. In contrast to ADAR1 knockdown, after ADAR2
knockdown, the levels of 2,240 A-to-G sites increased by 20%
or more (Figure 4B). We reasoned that these sites (e.g., those
in EIF2AK2) are mainly targeted by ADAR1; therefore, following
ADAR2 knockdown, a compensatory increase in ADAR1 binding
or activity would lead to higher editing levels, which would
be abolished by the simultaneous silencing of ADAR1 and
ADAR2. This hypothesis was confirmed by a decrease in
EIF2AK2 editing following double knockdown of ADAR1 and
ADAR2 (Figure 3C). The compensation is not due to higherll Reports 5, 849–860, November 14, 2013 ª2013 The Authors 853
Table 1. Hyperedited Transcripts
Hyperedited Region Gene Symbol
Number of
Edited Sites
chr9:131701274-131841654 FNBP1 291
chr3:47608175-47795690 SMARCC1 218
chr1:1713762-1810015 GNB1 214
chr4:39379937-39452078 UBE2K 167
chr5:138923557-138985907 UBE2D2 162
chr8:98728784-98810463 MTDH 154
chr15:42553696-42603223 CTDSPL2 148
chr1:149438531-149485085 PIP5K1A 141
chr10:70152450-70219274 CCAR1 138
chr17:24746313-24892874 TAOK1 136
chr16:68968176-69027669 ST3GAL2 134
chr5:176497466-176651020 NSD1 134
chr2:61559886-61613430 XPO1 133
chr3:49046623-49101020 QRICH1 131
chr12:49088991-49144511 LARP4 128
chr16:15655703-15700735 NDE1 128
chr1:149652924-149695116 POGZ 127
chr19:17076438-17180447 MYO9B 127
chr19:16604467-16625697 C19orf42 125
chr16:88337701-88409128 FANCA 123ADAR1 protein expression, since it increased only minimally
following ADAR2 knockdown (Figure 4C). These results suggest
that the increase in editing levels following ADAR2 knockdown
could be due to increased availability of the sites to ADAR1
and/or homodimerization of ADAR1, a more active form of
ADAR1 (Chilibeck et al., 2006; Lehmann and Bass, 2000).
Shared Editing Targets of ADAR1 and ADAR2
Next, we examined the specificity of ADAR1 and ADAR2 by
comparing editing sites identified from the knockdown experi-
ments described above. We found that the editing levels of
6,771 sites decreased after at least one of the ADAR proteins
was silenced. Of these, 1,668 sites showed a reduction in editing
levels by R20% following knockdown of ADAR1 and ADAR2,
suggesting they are targets of both enzymes (Figure 4D; Tables
S3 and S4). These included sites in genes that encode the DNA
damage repair protein ERCC4 and the telomerase-associated
protein TEP1. Other targets appeared to be specific to ADAR1
or ADAR2: 4,590 sites showed a decrease in levels following
only ADAR1 silencing, and 513 sites showed a decrease only
in ADAR2 knockdown (Figure 4D). The extent of ADAR2 knock-
down is smaller than that of ADAR1 knockdown, which could
account for the more modest decrease in A-to-G editing
following ADAR2 knockdown.
RNA-IP Uncovered Many Additional A-to-G Editing Sites
ADAR deaminases are RNA-binding proteins that interact
directly with their substrates (Klaue et al., 2003). To understand
the RNA-binding activity of ADAR1, we carried out native IP of
ADAR1 in B cells and sequenced the RNA that coprecipitated854 Cell Reports 5, 849–860, November 14, 2013 ª2013 The Authorswith the ADAR1 protein (Figure 4E). Previously, we selected pol-
yadenylated mRNAs for analysis in order to obtain adequate
sequence coverage. Here, we targeted the IP to RNAs that
are specifically bound to ADAR1 in vivo without selecting for
polyadenylated mRNAs. This allowed us to study the effects of
ADAR1 on a broader set of RNAs, including immature transcripts
whose introns have yet to be spliced out. To test the quality of the
ADAR RNA-IP, we showed that known ADAR1 substrates, such
as EIF2AK2 and AZIN1, were bound by ADAR1 protein, in
contrast to the control transcript PPWD1, which is not edited
(Figure 4F). We next carried out RNA-seq analysis and identified
edited transcripts that were pulled down by ADAR1 antibody but
not by negative-control immunoglobulin G (IgG). Using the same
thresholds as above, we identified 55,719 A-to-G sites in the
two individuals, which is far more than the 10,412 editing sites
identified from the mRNA samples of the same individuals (Table
S5). Transcripts that are bound and edited by ADAR1 protein
include those that encode WEE1, a protein kinase that plays a
role in DNA replication, and COPB1, a member of the coatomer
protein complex that is involved in trafficking between the
Golgi and the endoplasmic reticulum.
Of these 55,719 sites, fewer than 4,500 sites have been previ-
ously reported (Bahn et al., 2012; Carmi et al., 2011; Kiran and
Baranov, 2010; Li et al., 2009; Peng et al., 2012). The majority
(81%) of the sites were found in introns and some were found
in lncRNAs, including LINC00265 and LINC00476. The tran-
scripts from the RNA-IP were hyperedited: >30% of the editing
sites clustered in 224 transcripts, each of which had >50 A-to-
G editing sites (Table 1). More than 97% of the 55,719 editing
sites were in Alu repeats that promote dsRNA formation and
therefore binding and hyperediting by ADAR proteins (Osenberg
et al., 2009). When we examined a hyperedited region of ATM
more closely, we found that each adenosine was deaminated.
However, the editing level at a given site ranged from 1% to
99%, and within a given transcript there was no obvious pattern
as to which adenosine was edited (Figure 2B).
Features Differ between A-to-G Editing Sites
and Other Types of RDDs
The results from ADAR knockdown and RNA-IP suggest that
although ADARs mediate A-to-G editing, they do not mediate
other types of RDDs. The levels of other types of differences
were largely unaffected by ADAR knockdown, and the tran-
scripts that showed those differences were not bound by
ADAR. This prompted us to compare the genomic features
surrounding the A-to-G editing sites and other types of RDDs.
First, the sequence contexts of A-to-G and non-A-to-G sites
are different. The base 50 adjacent to the adenosine in A-to-G
sites is depleted of guanosine (G) and the base 30 to A-to-G
editing sites is enriched for G (Figure 5A), consistent with previ-
ous reports (Lehmann and Bass, 2000). This sequence feature
is specific to A-to-G editing because it is not present in random
adenosines within nonedited Alu repeats (data not shown). This
sequence motif was also not found for any of the RDDs. We
identified sequence motifs for G-to-A and T-to-C sites, and
they differed from the motif around the A-to-G sites (Figure 5A).
Second, the A-to-G sites were more clustered than the non-A-
to-G sites (67% of A-to-G sites were found within 25 nt of each
Figure 5. Features of A-to-G and RDD Sites
(A) The nucleotide 50 to A-to-G sites is depleted of
G, and the nucleotide 30 to A-to-G sites is enriched
for G. In contrast, the nucleotide 30 to G-to-A sites
is enriched for T, and the nucleotide 30 to T-to-C
sites is enriched for G. Sequences for 10 nt up-
stream and downstream of A-to-G or RDD sites
were analyzed and the frequencies of A, C, T, and
G at each position are shown. The horizontal line
at a frequency of 0.25 indicates the expected
frequency if the four nucleotides are represented
equally.
(B) A-to-G and other RDD sites are found in
different genomic regions. Upper panel: genome-
wide distribution (‘‘Mixed’’ indicates regions with
multiple or ambiguous annotation). Lower panel:
distribution in exonic regions.
(C) Sequence motifs for editing targets pulled
down in anti-ADAR RNA-IP assays. The MEME
program was used to analyze DNA sequences
corresponding to 100 nt upstream and down-
stream of editing sites. The four motifs that
are most significantly enriched in input sequences
are shown (p < 1010, Fisher’s exact test).
Scrambled sequences were used as negative-
control sequences.
(D and E) Expression levels of transcripts do not
correlate with editing levels. RPKM values of
transcripts measured in an ADAR1 knockdown
sample and a negative-control sample (NTC) are
plotted. Edited and nonedited transcripts are
indicated in different colors.
(D) All transcripts.
(E) Genes encoding zinc-finger proteins whose
expression levels changed byR20%.
See also Table S8.other, compared with 14% of non-A-to-G RDDs). Third, most
of the A-to-G sites were within or near inverted repeats, which
form dsRNA and are preferentially recognized and bound by
ADAR enzymes. Nearly 45% of the A-to-G sites resided within
inverted repeats and another 30% were found near inverted
repeats (<1 kb). In contrast, very few (0.9%) of the non-A-to-G
sites were found in inverted repeats. Lastly, A-to-G sites and
RDD sites were found in different regions of genes. A-to-G sites
were found mostly in the 30 UTRs, whereas RDDs were found
mainly in the 50 UTRs and in coding exons. Only 4% of the A-
to-G sites (compared with 35% of RDDs) were in coding exons
(Figure 5B). The differences between A-to-G editing sites and
the other types of RDDs suggest that they are mediated by
different mechanisms. Biochemically, this is expected since
some of the RDDs are transversion events that cannot be ex-
plained simply by deamination.Cell Reports 5, 849–860, NSequence Motifs near A-to-G
Editing Sites
The large number of RNA editing sites
in our study gave us an opportunity to
uncover characteristics of the editing tar-
gets. We expanded our sequence anal-
ysis to 100 nt upstream and downstreamof A-to-G sites using the motif discovery tool MEME (Bailey
et al., 2009). MEME identified four motifs that are significantly
enriched in the sequences surrounding the A-to-G editing sites
compared with control sequences (p < 1010, Fisher’s exact
test; Figure 5C). One of these motifs (TA(T/A)TTTT) corresponds
to the binding motif of HuR, an RNA-binding protein that regu-
lates mRNA turnover (Myer et al., 1997). Other studies have
also investigated the sequence and structure specificity of tar-
geted sites of ADAR enzymes (Bahn et al., 2012; Daniel et al.,
2012; Dawson et al., 2004; Kuttan and Bass, 2012; Lehmann and
Bass, 2000;Wonget al., 2001). However, the sequencemotifswe
described here have not been previously reported in ADAR edit-
ing targets. This is likely because we searched more distant se-
quences surrounding editing targets in a larger number of editing
sites of various types of RNAs, whereas most previous studies
focused on immediately adjacent sequences on fewer targets.ovember 14, 2013 ª2013 The Authors 855
Finding the HuR motif near ADAR-binding sites led us to
reason that ADAR interacts with other RNA-binding proteins.
The sequence motifs for RNA-binding proteins in edited tran-
scripts suggest cooperative binding among RNA processing
proteins, akin to the coupling seen in regulation of gene expres-
sion bymultiple transcription factors. This finding prompted us to
study the interactions between ADAR1 and HuR proteins (see
below).
ADAR Regulates Gene Expression
After examining how ADAR proteins affect RNA sequences, we
turned to study their effects on gene expression and to deter-
mine the relationship between RNA editing and gene expression.
We found that ADAR1 and ADAR2 affect the expression of thou-
sands of genes and their transcripts in human B cells. We looked
for genes that showed changes in the total gene-expression
level. Following ADAR1 knockdown, 635 genes showed signifi-
cant changes in gene expression in two individuals (p < 0.05; Ta-
ble S6). The RNA-seq data allowed us to analyze the effect of
ADAR on gene expression at single-nucleotide resolution to
quantify changes of transcript expression in addition to total
gene expression following ADAR1 knockdown. Many genes
demonstrate ‘‘isoform switching’’ under physiological or experi-
mental perturbations (Trapnell et al., 2013). The expression
levels of 1,238 transcripts showed significant changes in expres-
sion (Table S6). Nearly half of these transcripts (579) belong to
the genes that changed the total expression level. However,
changes in 659 transcripts were not reflected at the total gene-
expression level. For some transcripts, such as VNN2 and ARH-
GAP19, two isoforms showed changes in opposite directions,
and thus the total gene levels that are the sums of isoforms did
not show change (Figure S3C). Gene Ontology analysis (Huang
et al., 2009a) showed that these ADAR-regulated genes are en-
riched in kinase (p < 109), DNA damage response proteins (p <
1010), and zinc-finger proteins (p < 106; Table S7).
RNA-seq data provide information on editing and gene
expression in the same samples, and thus allow us to assess
the connection between the two. We examined the levels of
ADAR1-dependent editing and transcript expression, and found
that they were not correlated (r < 0.05 for both individuals).
Following ADAR1 knockdown, changes in expression level
were independent of the editing status of the target genes (Fig-
ure 5D). For example, among the 263 zinc-finger protein genes
whose expression levels changed following ADAR1 knockdown,
only 40% (104 genes) were editing targets of ADAR1. ADAR1
regulated the expression of zinc-finger proteins regardless of
whether theywere editing targets or not (Figure 5E). For instance,
the expression levels of ZNF16 decreased and those of ZNF432
increased following ADAR1 knockdown; however, even though
they both had multiple Alu repeats, neither gene was edited.
Therefore, editing of Alu is not required for ADAR1 to regulate
the expression of zinc-finger proteins (Shen et al., 2011).
Another way to investigate the relationship between RNA edit-
ing and gene-expression regulation is to study the 106 genes
that are both edited and regulated by ADAR1 at the mRNA
expression level (Table S8). Among these, following ADAR1
knockdown, the expression levels of 67 genes increased and
those of 39 genes decreased. Changes in editing levels and856 Cell Reports 5, 849–860, November 14, 2013 ª2013 The Authorsgene expression following ADAR1 knockdown were not signifi-
cantly correlated (r < 0.05). For example, IKZF3, a transcription
factor that regulates proliferation and differentiation of B lympho-
cytes, has 68 A-to-G editing sites. Its expression level increased
by 1.3-fold, whereas its editing level decreased by >7-fold
following ADAR1 knockdown. In contrast, both the editing and
expression levels of CENPN (43 A-to-G editing sites) decreased
following ADAR1 knockdown. The positions of edited sites
within genes (such as coding exons, 30 UTRs) and the number
of edited sites per transcript also did not correlate with changes
in expression followingADAR1 knockdown. These results further
suggest that ADAR1 can affect gene expression independently
of its deamination activity.
We also examined the editing and gene-expression regulatory
roles of ADAR2. Although ADAR2 has fewer editing targets than
ADAR1, it regulates the expression levels of more genes.
Following ADAR2 knockdown, the expression levels of 4,154
transcripts (in 3,379 genes) increased by 2-fold, and those of
872 transcripts (in 734 genes) decreased by 2-fold (Table S9).
Thus, ADAR2 has a broader effect on gene expression even
though it plays a lesser role in editing compared with ADAR1.
This further implies that ADAR proteins affect editing and gene
expression independently.
ADAR1 Interacts with HuR to Regulate Transcript
Stability
Our analysis of sequence motifs around editing sites identified
an enrichment of HuR-binding motifs. This motivated us to study
whether HuR and ADAR1 function cooperatively. HuR binds to
single-stranded RNA (ssRNA) and regulates transcript stability
and gene expression (Fan and Steitz, 1998). We carried out pro-
tein IP using anti-ADAR1 and negative-control IgG. We
confirmed specific pull-down of ADAR1 by immunoblotting,
and identification of transcripts and protein of EIF2AK2, a known
editing target and interacting partner of ADAR, in the immuno-
precipitates (Figure 6A; Clerzius et al., 2009). Using antibody
against HuR, we found that HuR was pulled down with ADAR1,
suggesting these two proteins interact in vivo (Figure 6B, lanes
4 and 5). As a control, ILF3, a protein that is known to interact
with ADAR1 in a dsRNA-dependent manner, was also pulled
down (Nie et al., 2005). Next, we asked whether the interaction
between ADAR1 and HuR is dependent on scaffold RNAs. We
carried out ADAR1-IP using RNase A- and RNase V1-treated
whole-cell lysates. RNase A treatment, which digests ssRNA,
abolished the interactions between HuR and ADAR1, but not
the interactions between ILF3 and ADAR1. In contrast, the
dsRNA-specific RNase V1 reduced the interactions between
HuR and ADAR1, and between ILF3 and ADAR1 (Figure 6B,
lanes 6–9). These results show that the interaction between
HuR and ADAR1 is dependent on both ssRNA and dsRNA.
To examine how ADAR and HuR interact with their RNA tar-
gets, we carried out additional analyses. First, we studied the
HuR-binding sites in ADAR-bound transcripts. As mentioned
above, we found that sequences of transcripts bound by ADARs
were enriched for AU-rich elements (AREs), which are HuR-bind-
ing sites. Among the 4,279 ADAR-bound transcripts, 4,198
(98%) had at least one and often many HuR-binding sites. There
were 172,000 TA(T/A)TTTT sites in ADAR-bound transcripts,
Figure 6. ADAR1 and HuR Proteins Interact
in an RNA-Dependent Manner and Coregu-
late Common Transcripts
(A) Anti-ADAR1-IP of ADAR1 and its interacting
protein EIF2AK2. Western blot analysis shows
that ADAR1 and EIF2AK2 are pulled down by
anti-ADAR1, but not by negative controls.
Confocal immunofluorescence analysis confirms
the interaction between ADAR1 and EIF2AK2 in
the nucleus. Arrows indicate orthogonal views of
colocalized ADAR1 and EIF2AK2.
(B) ADAR1 and HuR interact in vivo in an RNA-
dependent manner. RNase A and V1 treatment
before IP abolishes the interaction between
ADAR1 and HuR.
(C) RNA pull-down experiments showed that
HuR (top panel) and ADAR (bottom panel) bind to
the same target transcripts. A (polyA)25 RNA was
used as the negative-control transcript. Cell lysate
incubated with mock solution before pull-down
was included as the no-RNA control.
(D) ADAR1 and HuR antibodies, but not control
IgG, pulled down the same transcripts. Following
anti-ADAR1 and anti-HuR RNA-IP, quantitative
RT-PCR was carried out to measure the levels of
various transcripts. RNA levels bound by negative-
control IgG were normalized to one.
(E) ADAR1 knockdown leads to reduced binding
of HuR to their target transcripts. HuR RNA-IP was
carried out in cells treated with ADAR1-siRNA or NTC-siRNA, and the HuR-associated transcript level was measured by quantitative RT-PCR.
(F) The gene expression of the target transcripts of HuR and ADAR1 was reduced following ADAR1 knockdown. Gene expression levels from RNA-seq data
(RPKM) were normalized to those obtained from NTC-siRNA samples.
Error bar indicates SEM. See also Tables S2 and S4.significantly more (c2, p < 0.0001) than in control transcripts
(68% of 4,279 random control transcripts contain 79,084
AREs). Similarly, other HuR-binding sequences (including (U/A)
UUUA, (U/C)UUUA, and AUUU(U/C); Mukherjee et al., 2011)
were also enriched in ADAR-bound transcripts. Second, since
the presence of AREs does not mean that HuR binds to them,
we confirmed the binding using PAR-CLIP data (Kishore et al.,
2011; Lebedeva et al., 2011; Mukherjee et al., 2011). Among
the 4,279 transcripts bound by ADAR1, 2,866 (67%) were also
bound by HuR in PAR-CLIP, which is significantly more than
observed in random transcripts (36%; c2, p < 0.0001), showing
that HuR binds to ADAR1 targets in vivo. These common binding
targets of HuR and ADAR1 include MCM4, which plays a key
role in DNA replication; TMPO, which encodes a nuclear mem-
brane protein; and GSR, which encodes the enzyme glutathione
reductase in the antioxidative stress pathway.
The enrichment of HuR-binding sites in ADAR targets and the
identification of an RNA-dependent HuR-ADAR complex led us
to reason that HuR and ADAR bind to common transcripts and
regulate them cooperatively. We confirmed our hypothesis by
employing two experimental approaches. First, we carried out
RNA pull-down assays. We prepared in vitro synthesized and
biotinylated RNA for three transcripts (MCM4, CTH, and GSR)
that we previously identified as shared targets of ADAR and
HuR. After incubating these transcripts with B cell lysates,
we pulled down the transcripts using their biotin tags and
immunoblotted for ADAR and HuR proteins. Our results showedCethat ADAR and HuR are specifically pulled down on MCM4
and GSR transcripts, confirming concurrent ADAR and HuR
binding (Figure 6C). Although it binds strongly to HuR, the CTH
transcript pulled down less ADAR1, suggesting its weaker
interaction with ADAR1 compared with MCM4 and GSR.
Second, we carried out HuR RNA-IP to confirm that HuR
binds to the same transcripts that ADAR1 targets, and then
examined the effects of such binding. Using HuR antibody, we
pulled down HuR protein and tested whether ADAR1-targeted
transcripts were pulled down with HuR in human B cells. The
results showed that HuR antibody, but not negative-control
IgG, pulled down the same transcripts that immunoprecipitated
with ADAR1 antibody, including MCM4, TMPO, GSR, and CTH
(Figure 6D).
We then asked whether HuR and ADAR1 depend on each
other for binding to their common targets. Previous studies
have found that HuR and other RNA-binding proteins cooperate
by binding to the same RNA substrates (Chang et al., 2010;
Lal et al., 2004). We carried out HuR RNA-IP following siRNA
knockdown of ADAR1 and found that following ADAR1 knock-
down, binding of HuR to its target transcripts is greatly reduced
(Figure 6E). In cells transfected with ADAR1 siRNAs, the protein
level in HuR is the same as that in controls (Figure S2B), confirm-
ing that the decrease in HuR binding is not due to decreased
HuR protein expression.
After identifying that ADAR is required for HuR binding to
transcripts, we examined the effects of ADAR and HuR onll Reports 5, 849–860, November 14, 2013 ª2013 The Authors 857
transcript levels. Since HuR regulates gene expression by
stabilizing mRNAs (Myer et al., 1997), we examined whether
ADAR binding affects transcript stability through HuR. Among
the 775 genes whose expression levels decreased following
ADAR1 knockdown, there were significantly more genes con-
taining HuR-binding sites than genes whose expression levels
increased following ADAR1 knockdown (c2, p < 0.01). For
example, the expression levels of MCM4, TMPO, GSR, and
CTH transcripts were reduced in both individuals following
ADAR1 knockdown, consistent with binding of their transcripts
by both HuR and ADAR1 (Figure 6F). These results support the
notion that in the absence of ADAR1, HuR binding decreased;
thus, the target genes were not stabilized, resulting in lower
gene expression. Lastly, these data suggest that ADAR1 and
HuR expression levels should correlate with the expression
levels of their target genes. Using results from another study in
our lab (Cheung et al., 2010), we compared the expression levels
of the target genes with ADAR1 and HuR in cultured B cells from
41 unrelated individuals and found that they were significantly
correlated (p << 0.01). Correlation plots for MCM4 and TMPO
with ADAR1 and HuR are shown in Figure S4A.
Our findings suggest that ADAR1 and HuR proteins cooperate
to regulate RNA processing through editing and mRNA turnover.
These proteins coregulate transcripts by binding to specific
sequences and secondary structures that mediate these pro-
cessing steps.
DISCUSSION
In this study, we uncovered 60,000 A-to-G RNA editing sites
mediated by ADAR1 and ADAR2 proteins in human B cells. We
show that ADAR proteins are involved in gene regulation,
particularly in regulating RNA stability and processing.
Prior to our study, many A-to-G editing sites had been iden-
tified. Here, we added to the list of such sites by using gene
knockdown and RNA-IP, and we validated experimentally
that our sites are direct targets of ADAR1 and ADAR2 proteins.
Traditionally, editing sites are identified by comparing DNA
and RNA sequences. Often the DNA sequences used for com-
parisons are those from the reference genome. We extracted
the DNA and RNA from the same cells and subjected them
to deep sequencing, which allowed a direct comparison of
RNA sequences and their corresponding DNA. Although NGS
provides sequence information with unprecedented coverage,
there are hundreds of millions of sequence reads that have
to be mapped correctly for proper interpretation. To have
confidence in our sequence mapping, we set stringent analysis
thresholds that required uniquely mapped reads from two
different sequence alignment algorithms (GSNAP and blat)
and at least ten sequence reads at each site. However, com-
putational analysis alone may not be adequate. To determine
a list of high-confidence ADAR targets, we coupled deep
sequencing with ADAR gene knockdowns and ADAR RNA-IP.
The same analysis method was used to analyze sequence
reads from all samples, and thus the sites in which editing
is responsive to gene knockdown, or that are bound specif-
ically to ADAR proteins, cannot be artifacts of computational
analyses. In a recent study on RNA editing in Drosophila858 Cell Reports 5, 849–860, November 14, 2013 ª2013 The Authors(Rodriguez et al., 2012), RNA-seq of nascent RNA from an
ADAR null strain was compared with that of a wild-type strain.
The results were used to estimate an FDR of 5%. In our
study, we used a similar approach and estimated our FDR
to be 4%.
The large number of sites in which RNA sequences differed
from the underlying DNA sequences is surprising and requires
further attention in genetic studies. Results from this and other
studies show that there are likely many thousands of A-to-G
editing sites in each individual. Previously, we showed that
there are individual differences in the number of RDDs (Li et al.,
2011). Here, in our two subjects, we also observed differences
in the number of editing sites and the level of editing. These
results indicate that genetic variation can extend beyond DNA
sequence variation. Even though two individuals may have the
same DNA sequences at a site, their RNA sequences may differ.
To date, most genetic studies have focused on DNA sequence
variation in looking for disease-susceptibility alleles. As it be-
comes clear that RNA sequence variation extends beyond
DNA sequence polymorphism, RNA editing and other types
of RDDs will have to be considered in studies to identify the
genetic basis of human diseases and traits. Comprehensive
lists of editing and RDD sites, such as those presented in this
study, are important for facilitating the inclusion of RNA variants
in genetic studies.
RNA transcripts are tethered to regulatory factors, and the
combinatorial binding of RBPs to transcripts coordinates
different steps of RNA processing (Hogan et al., 2008; Licatalosi
and Darnell, 2010; Maniatis and Reed, 2002). We found enrich-
ment of binding sequences for HuR in transcripts edited by
ADAR. Computational and experimental evidence from HuR
RNA-IP in human B cells and cells transfected with ADAR
siRNAs showed that HuR binding is facilitated by ADAR binding
to RNAs. Our results are consistent with a model in which
binding of ADAR to RNA forms secondary structures that are
then recognized by HuR proteins. Thus, RNA sequences and
structures allow gene regulation by a combination of different
RNA processing proteins. Transcription factors cooperate to
mediate gene regulation; similarly, RNA processing proteins
coordinate to affect gene expression. The complex regulatory
codes involve RNA sequences and structures that are facili-
tated by different combinations of RNA-binding proteins. There-
fore, to understand co- and posttranscriptional regulation of
gene expression, we need to go beyond studying single pro-
teins. Experimental methods that examine protein complexes
and their target RNAs are needed to enhance our understanding
of gene regulation.
In summary, in this work we studied ADAR-mediated RNA
editing and gene-expression regulation. Our findings uncover
editing targets, reveal ADARs’ role in mediating RNA editing
and regulation of gene expression, and show that the
ADAR protein complex coordinates multiple steps in RNA pro-
cessing. However, they also raise new questions. Our findings
suggest that other mechanisms, such as those that mediate
non-A-to-G type RDDs, remain to be identified. In addition,
the RNA sequence and structural signatures of the regu-
latory codes for co- and posttranscriptional processing are
largely unknown. Elucidating ADAR’s functions will further our
understanding of RNA processing and provide insights into hu-
man diseases.
EXPERIMENTAL PROCEDURES
Identification of Editing and RDDs
B cell lines from two individuals in the Centre d’E´tude du Polymorphisme
Humain database were cultured and genomic DNA and RNA were extracted.
DNA-seq and RNA-seq libraries were prepared and sequenced on a HiSeq
2000 instrument (Illumina). DNA-seq and RNA-seq data were aligned to the
reference genome (HG18) using CASAVA and GSNAP, respectively. To iden-
tify RDDs, we compared each RNA sequence with its corresponding DNA
sequence. We required an editing site or RDD site to be covered by aminimum
of 10 total DNA-seq and RNA-seq reads, 100% concordance in the DNA
sequence, an RDD level R 10%, and an RDD event to be found in both
individuals. Potential sites were then filtered using stringent thresholds.
Validation of RDDs using Sanger Sequencing and Droplet Digital
PCR
Cultured B cells were transfected with Accell siRNAs (Thermo Scientific)
against ADAR1 and ADAR2. Sequences surrounding RDD sites were PCR
amplified using genomic DNA or cDNA as the template, and PCR products
were sequenced. The 30 UTR of ATM was amplified from cDNA of B cells
and cloned into TOPO vector (Invitrogen).
For droplet digital PCR, DNA probes specific to the DNA and RNA variants at
RDD sites were synthesized and labeled by VIC and FAM, respectively (ABI
Biosystems). Emulsion PCR was carried out and quantified on a QuantaLIfe
Droplet Reader (Bio-Rad Laboratories).
RNA-IP
Anti-ADAR1 and anti-HuR RNA-IP was carried out with a Magna RNA-Binding
Protein Immunoprecipitation Kit (Millipore). Quantitative PCR and RNA-seq of
immunoprecipitated transcripts were carried out. RNA-editing sites that were
detected in transcripts pulled down by ADAR1 antibody, but not by negative-
control IgG, were identified as ADAR1-specific targets.
RNA-Protein Pull-Down Assays
Transcripts of HuR and ADAR1 targets were synthesized and biotin labeled
in vitro, and incubated with whole-cell lysates. RNA-protein complexes were
pulled down and analyzed by western blot (Pierce).
Protein IP of the ADAR-HuR Complex
B cell lysates were incubated with anti-ADAR1 or negative-control rabbit IgG
at 4C overnight. The immunocomplex was pulled down using Protein A
agarose (Roche), washed, and finally eluted in 20 mM Tris/7.5, 150 mM
NaCl, 2.5 mM MgCl2, 0.2% SDS. To examine RNA-dependent interactions,
whole-cell lysates were diluted to 1 mg/ml, RNase A or RNase V1 was added,
and lysates were incubated at room temperature for 15 min. Protein samples
were analyzed by western blot.
A detailed description of the materials and methods used in this work is
provided in the Supplemental Experimental Procedures.
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